Neuroglee Therapeutics discovers, develops, and commercializes software as medical treatment for patients with neurodegenerative diseases. By combining best-in-class cognitive rehabilitation strategies and machine learning approaches, our digital therapeutic and monitoring tools empower patients, families and clinicians by helping to preserve cognition and independence. Our lead product, NG-001 is a prescription software intended for treatment of MCI and patients with early stage Alzheimer's Disease. For more information, visit us at www.neuroglee.com